❌ « Hits » from off-target effects
❌ Missing disease-relevant opportunities
✅ MyoScreen™ changes that.
We combine:
- Patient-relevant muscle disease models
- High-content imaging at scale
- AI-powered phenotypic analysis
- CRISPR/siRNA screening in 384-well format
The difference? Targets validated under actual disease conditions—giving you confidence before committing to costly development.
📊 Do you want to see our case study AI-driven target identification in DMD ?
Do you want to discuss your Target ID & Validation needs? Contact us !
